United States · FDA National Drug Code directory
PredniSONE Tablets, USP, 20 mg
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72789-509_536e3e07-924e-b3f6-e063-6394a90a1813
- Product NDC
- 72789-509
- Form
- TABLET
- Composition / generic term
- PredniSONE
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250522
- Source listing expiry
- 20271231
Source-listed ingredients
- PREDNISONE — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 TABLET in 1 BOTTLE, PLASTIC (72789-509-06) · 72789-509-06
- 9 TABLET in 1 BOTTLE, PLASTIC (72789-509-09) · 72789-509-09
- 12 TABLET in 1 BOTTLE, PLASTIC (72789-509-12) · 72789-509-12
- 15 TABLET in 1 BOTTLE, PLASTIC (72789-509-15) · 72789-509-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →